Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) Other Operating Expenses (2016 - 2026)

Pediatrix Medical (MD) has disclosed Other Operating Expenses for 17 consecutive years, with $361.0 million as the latest value for Q1 2025.

  • Quarterly Other Operating Expenses fell 12.05% to $361.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $361.0 million through Dec 2025, down 9.92% year-over-year, with the annual reading at -$9.7 million for FY2024, N/A changed from the prior year.
  • Other Operating Expenses for Q1 2025 was $361.0 million at Pediatrix Medical, up from $1.2 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $410.5 million in Q1 2024, with the low at -$10.9 million in Q2 2024.
  • Average Other Operating Expenses over 5 years is $294.8 million, with a median of $365.8 million recorded in 2021.
  • The sharpest move saw Other Operating Expenses increased 16.35% in 2021, then decreased 12.05% in 2025.
  • Over 5 years, Other Operating Expenses stood at $368.5 million in 2021, then increased by 10.5% to $407.2 million in 2022, then decreased by 1.29% to $401.9 million in 2023, then crashed by 99.69% to $1.2 million in 2024, then surged by 29182.16% to $361.0 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $361.0 million, $1.2 million, and -$59000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.